Salute e Benessere

Accord Healthcare is granted marketing authorisation for IMULDOSA®, ustekinumab…

Ustekinumab is a human monoclonal antibody that targets the cytokines interleukin-12 and interleukin-23 which may play an important role in inflammatory and immune responses. Stelara® is indicated for range of immune medicated inflammatory diseases and has recorded global sales of US$ 19 billion of which US$D 3.2 billion sales coming from Europe as per IQVIA MAT Jun'24 data. Ustekinumab is a human monoclonal antibody that targets the cytokines interleukin-12 and interleukin-23 which may play…
PR Newswire
16/12/2024

Pharming announces public cash offer to the shareholders of Abliva AB

Proposed acquisition strengthens Pharming's late-stage pipeline with a potential first-in-disease assetAbliva's lead product KL1333 is currently in a pivotal clinical trial, with a positive interim analysis achieved, in mitochondrial DNA-driven primary mitochondrial diseasesTotal transaction value of approximately US$66.1 millionNo external funding required to fund acquisition and KL1333 development costsPharming to host a conference call on Monday, December 16, 2024...
Nasdaq GlobeNewswire
15/12/2024

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related…

Bagsværd, Denmark, 14 December 2024 — As of today, all regulatory closing conditions relating to the review of Novo Holdings A/S's pending acquisition of Catalent, Inc. (Catalent), including expiry of the timing agreement in the US, have been fulfilled. Catalent is a global contract development and manufacturing organisation headquartered in New Jersey (US). The parties are now free to close the transaction, as well as Novo Nordisk's subsequent acquisition of three Catalent manufacturing...
Nasdaq GlobeNewswire
14/12/2024

BIOVAXYS ANNOUNCES CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT AND ANNOUNCES…

Each Unit consist of one (1) common share in the capital of the Company (each, a "Share") and one (1) whole Share purchase warrant (each, a "Warrant"), whereby each Warrant is convertible into one additional Share at an exercise price of $0.15 until December 13, 2026, being the date that is 24 months from the date of issue. Each Unit consist of one (1) common share in the capital of the Company (each, a " Share ") and one (1) whole Share purchase warrant (each, a…
PR Newswire
14/12/2024

Groupe Casino - Nombre de droits de vote et d'actions 30-11-2024

CASINO, GUICHARD-PERRACHON Société anonyme au capital de 4 009 397,13 € Siège social : 1, Cours Antoine Guichard 42000 Saint-Etienne 554 501 171 R.C.S. Saint-Etienne Informations relatives au nombre total de droits de vote et d'actions composant le capital social au 30 novembre 2024(article 223-16 du Règlement Général de l'Autorité des Marchés Financiers)Nombre d'actions composant le capitalNombre total de droits de voteNombre total de droits de vote exerçables en...
Nasdaq GlobeNewswire
13/12/2024

Report of transactions of shares and related securities of Bavarian Nordic by…

COPENHAGEN, Denmark, December 13, 2024– Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company's shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. 1.Details of the person discharging managerial responsibilities/person closely associated a)NamePaul Chaplin 2.Reason for the notification a)Position/status President and ...
Nasdaq GlobeNewswire
13/12/2024

Medical Writing Market Size Indicating $ 9.09 billion by 2031, Featuring…

The medical writing market is growing owing to the expansion of the pharmaceutical, biotechnology, and medical device industries, along with an increase in clinical trials and drug development. Moreover, the growing emphasis on personalized medicine, stricter regulatory requirements, and globalization of healthcare are expected to favor market growth in the coming years. The medical writing market is growing owing to the expansion of the pharmaceutical, biotechnology, and medical device...
PR Newswire
13/12/2024

Fusion Biopsy Market to Hit USD 0.91 Billion by 2029 with 7.1% CAGR |…

Browse in-depth TOC on "Fusion Biopsy Market" Browse in-depth TOC on "Fusion Biopsy Market" 191 - Tables 45 - Figures 196 - Pages Fusion biopsy systems use MRI and ultrasound together to create a detailed 3D image of the prostate, helping doctors accurately find and target abnormal tissue while guiding the biopsy needle with precision. Based on route type,the global fusion biopsy market can be divided into three segments: transrectal, transperineal, and other route...
PR Newswire
13/12/2024

Patient Controlled Injectors Market Size Set for Explosive Growth, With…

Market leaders and key company profiles Market leaders and key company profiles Request a Customized Copy of the Patient Controlled Injectors Market Report @https://www.theinsightpartners.com/reports/patient-controlled-injectors-market/ Overview of Report Findings South and Central America [Brazil, Argentina, Rest of South and Central America] Middle East and Africa [South Africa, Saudi Arabia, UAE and Rest of Middle East and Africa] Market...
PR Newswire
13/12/2024

Healthcare Revenue Cycle Management (RCM) Market Surges to USD 658.7 Billion by…

The Healthcare Revenue Cycle Management (RCM) market is driven by the growing adoption of electronic health records (EHR) systems, increasing demand for cost-efficient healthcare services, and regulatory changes that mandate accurate billing and coding. The rise in healthcare expenditures and the shift toward value-based care models further support the market's expansion. The Healthcare Revenue Cycle Management (RCM) market is driven by the growing adoption of electronic health records (EHR)...
PR Newswire
13/12/2024

SURPRISE: Checo Perez Surprises Oracle Red Bull Racing Team with PATRÓN EL ALTO…

A Media Snippet accompanying this announcement is available by clicking on thislink.JALISCO, Mecixo, Dec.13, 2024(GLOBE NEWSWIRE) -- Just ahead of the holidays, Formula 1 Mexican racing icon Checo Perez surprised the entire Oracle Red Bull Racing team by showing up at the ORBR headquarters in Milton Keynes, U.K. with the ultimate holiday gift; the soon-to-be-released prestige tequilaPATRÓN EL ALTO. Driving up in a festive PATRÓN EL ALTO wrapped truck, Checo delivered 2,000...
Nasdaq GlobeNewswire
13/12/2024

The Esthetic Clinics® Attracts 15% Global Patients to India, Amid Cosmetic…

Dr Debraj Shome is the only American Board Certified Facial Cosmetic Surgeon in India and serves as the Governor At Large of the Indian Chapter of the American College of Surgeons. DrDebraj Shomeis the only American Board Certified Facial Cosmetic Surgeon inIndiaand serves as the Governor At Large of the Indian Chapter of the American College of Surgeons. A recent success story at The Esthetic Clinics® isAshley Baker, a transgender woman from the US who underwent facial...
PR Newswire
13/12/2024

Bulletin from the extraordinary general meeting in SciBase Holding AB (publ)

Rights issue Rights issue The extraordinary general meeting resolved, in accordance with the board of directors' proposal, to approve the board of directors' resolution taken on12 November 2024to carry out a new issue of units with preferential rights for existing shareholders. The right to subscribe for units is granted to those who are registered as shareholders in the Company on the record date as of 20 December 2024. Each shareholder receives one (1) unit right per share held...
PR Newswire
13/12/2024

Diamyd Medical Aligns with FDA on Key Elements for an Accelerated Approval…

The early readout, planned for March 2026 for the ongoing Phase 3 DIAGNODE-3 trial, will include approximately 170 evaluable participants who have completed their 15-month assessment. As of today, 191 patients have been randomized in the trial. This analysis will provide efficacy data based on preservation of C-peptide levels, which the FDA, following a Type C meeting held in July 2024 with Diamyd Medical, recognizes as a surrogate endpoint reasonably likely to predict clinical benefit in Type 1…
PR Newswire
13/12/2024

Experience Beauty with Digital Human Technology: 'Twinit' Ventures into Global…

Twinit, developed by EntreReality, analyzes individual skin characteristics using Vision AI, providing a comprehensive solution to enhance cosmetic sales for brands. This technology examines skin tone, shape, and aging through 3D vision capabilities. As a key advantage, Twinit has partnered with major beauty brands, including South Korea's largest cosmetics company, Amorepacific. Additionally, the solution is deployed in large retail venues such as Incheon International Airport and Hyundai…
PR Newswire
13/12/2024

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England First patients implanted with Genioat UCLH, LondonMont-Saint-Guibert, Belgium – December 13, 2024, 8:05am CET / 2:05am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced the commercial launch of its Genio system in England, marked by...
Nasdaq GlobeNewswire
13/12/2024

New Incentive Program Established for Members of Executive Management and…

COPENHAGEN, Denmark, December 13, 2024– Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to establish a new long-term incentive program for Executive Management and selected employees in the Bavarian Nordic Group. Members of the Executive Management are granted a mix of performance restricted stock units (Performance RSUs) and warrants, both subject to the successful achievement of relevant Key Performance Indicators (KPI's). Employees participating in...
Nasdaq GlobeNewswire
13/12/2024

Roche's Vabysmo prefilled syringe (PFS) approved in the EU for three retinal…

Vabysmo PFS is the first and only prefilled syringe containing a bispecific antibody, offering a convenient alternative to currently available Vabysmo vialsVabysmo has demonstrated rapid and robust vision and anatomical improvements in neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME) and retinal vein occlusion (RVO)The ready-to-use Vabysmo PFS is co-packaged with the only CE-marked needle specifically designed for intravitreal injection Basel, 13...
Nasdaq GlobeNewswire
13/12/2024

Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems…

The new cobas 6800/8800 systems 2.0 enhances throughput, run flexibility, enables sample prioritisation and is available as an upgrade to existing systems in healthcare settings around the world.Laboratories can now perform a wider range of tests on a single solution, simplifying laboratory logistics and helping to optimise the use of resources.Basel, 13 December 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the CE certification of the new cobas® 6800/8800 systems 2.0...
Nasdaq GlobeNewswire
13/12/2024

Press Release: Tolebrutinib designated Breakthrough Therapy by the FDA…

Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosisDesignation is based on positive results from the HERCULES study in adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS)Tolebrutinib is the first and only brain-penetrant BTK inhibitor in MS to be designated Breakthrough Therapy by the FDA Paris, December 13, 2024.The US Food and Drug Administration (FDA) has granted Breakthrough Therapy...
Nasdaq GlobeNewswire
13/12/2024

Midea Strengthens Global Presence in the Heat Pump Industry with Optimistic…

Recognized as one of the 10 Breakthrough Technologies of 2024 by MIT Technology Review, heat pump technology is a pivotal innovation in reducing global reliance on fossil fuels and advancing carbon neutrality. Guan anticipates a strong market recovery over the next two years, driven by technological advancements, supportive policies, and increasing consumer awareness. Recognized asone of the 10 Breakthrough Technologies of 2024 by MIT Technology Review, heat pump technology is a pivotal...
PR Newswire
13/12/2024

Global Hematology Market to Exhibit Growth at a CAGR of ~8% by 2030 |…

Key Takeaways from the Hematology Market Report Key Takeaways from the Hematology Market Report To read more about the latest highlights related to the hematology market, get a snapshot of the key highlights entailed in theGlobal Hematology Market Report Hematology Overview Hematology is a specialized branch of medicine that focuses on the study, diagnosis, treatment, and prevention of blood-related disorders and diseases. It encompasses a wide range of conditions, including...
PR Newswire
12/12/2024

Innocan Pharma Provides its Annual "State of Research and Development" Update…

On the veterinary front, LPT-CBD's innovation was recognized by the FDA's Center for Veterinary Medicine (CVM), which granted Innocan a fee waiver for 2024 and issued a number that identifies an Investigational New Animal Drug (INAD). This designation allows Innocan to facilitate correspondence and data exchange with the CVM to support the development of LPT-CBD as a new veterinary drug. On the veterinary front, LPT-CBD's innovation was recognized by the FDA's Center for Veterinary Medicine...
PR Newswire
12/12/2024

Results of the votes of the Combined Shareholders' General Meeting of December…

Daix (France), New York City (New York, United States), December 11, 2024– Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), also known as non-alcoholic steatohepatitis (“NASH”), and other diseases with significant unmet medical needs, today announced the results of the votes of its Combined...
Nasdaq GlobeNewswire
12/12/2024
Altri  Comunicati